Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita
- PMID: 22341970
- PMCID: PMC3309184
- DOI: 10.1016/j.ajhg.2012.01.004
Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita
Abstract
Revertant mosaicism is an infrequently observed phenomenon caused by spontaneous correction of a pathogenic allele. We have observed such reversions caused by mitotic recombination of mutant TERC (telomerase RNA component) alleles in six patients from four families affected by dyskeratosis congenita (DC). DC is a multisystem disorder characterized by mucocutaneous abnormalities, dystrophic nails, bone-marrow failure, lung fibrosis, liver cirrhosis, and cancer. We identified a 4 nt deletion in TERC in a family with an autosomal-dominant form of DC. In two affected brothers without bone-marrow failure, sequence analysis revealed pronounced overrepresentation of the wild-type allele in blood cells, whereas no such skewing was observed in the other tissues tested. These observations suggest that this mosaic pattern might have resulted from somatic reversion of the mutated allele to the normal allele in blood-forming cells. SNP-microarray analysis on blood DNA from the two brothers indeed showed independent events of acquired segmental isodisomy of chromosome 3q, including TERC, indicating that the reversions must have resulted from mitotic recombination events. Subsequently, after developing a highly sensitive method of detecting mosaic homozygosity, we have found four additional cases with a mosaic-reversion pattern in blood cells; these four cases are part of a cohort of 17 individuals with germline TERC mutations. This shows that revertant mosaicism is a recurrent event in DC. This finding has important implications for improving diagnostic testing and understanding the variable phenotype of DC.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures




Similar articles
-
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.Hum Mol Genet. 2007 Jul 1;16(13):1619-29. doi: 10.1093/hmg/ddm111. Epub 2007 May 16. Hum Mol Genet. 2007. PMID: 17507419 Free PMC article.
-
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.Nat Genet. 2004 May;36(5):447-9. doi: 10.1038/ng1346. Epub 2004 Apr 18. Nat Genet. 2004. PMID: 15098033
-
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.Exp Dermatol. 2010 Mar;19(3):279-88. doi: 10.1111/j.1600-0625.2009.00916.x. Epub 2009 Jun 23. Exp Dermatol. 2010. PMID: 19558498 Free PMC article.
-
Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.Expert Rev Mol Med. 2004 Dec 20;6(26):1-23. doi: 10.1017/S1462399404008671. Expert Rev Mol Med. 2004. PMID: 15613268 Review.
-
Dyskeratosis congenita and telomerase.Curr Opin Pediatr. 2004 Feb;16(1):23-8. doi: 10.1097/00008480-200402000-00006. Curr Opin Pediatr. 2004. PMID: 14758110 Review.
Cited by
-
Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland.Hum Genet. 2021 Jul;140(7):1011-1029. doi: 10.1007/s00439-021-02268-1. Epub 2021 Mar 12. Hum Genet. 2021. PMID: 33710394 Free PMC article.
-
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.Curr Hematol Malig Rep. 2023 Oct;18(5):121-129. doi: 10.1007/s11899-023-00699-3. Epub 2023 Jun 1. Curr Hematol Malig Rep. 2023. PMID: 37261703 Free PMC article. Review.
-
Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime.J Med Genet. 2013 Jan;50(1):1-10. doi: 10.1136/jmedgenet-2012-101322. Epub 2012 Nov 21. J Med Genet. 2013. PMID: 23172682 Free PMC article. Review.
-
Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your Eyes.Biomedicines. 2022 Aug 29;10(9):2118. doi: 10.3390/biomedicines10092118. Biomedicines. 2022. PMID: 36140224 Free PMC article. Review.
-
Dysfunctional telomeres and hematological disorders.Differentiation. 2018 Mar-Apr;100:1-11. doi: 10.1016/j.diff.2018.01.001. Epub 2018 Jan 4. Differentiation. 2018. PMID: 29331736 Free PMC article. Review.
References
-
- Vulliamy T.J., Dokal I. Dyskeratosis congenita: The diverse clinical presentation of mutations in the telomerase complex. Biochimie. 2008;90:122–130. - PubMed
-
- Blackburn E.H. Structure and function of telomeres. Nature. 1991;350:569–573. - PubMed
-
- d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426:194–198. - PubMed
-
- Morin G.B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521–529. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials